Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07115342Recruiting
Randomised, open-label trial (2 arms), sponsored by Tanta University. Primary endpoints: Total Nasal Symptom Score at 12 weeks and Quality of Life at 12 weeks. Started Aug 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07115342.